1. Malaviya AN (2016) Low-dose methotrexate (LD-MTX) in rheumatology practice - a most widely misunderstood drug. Curr Rheumatol Rev 12:168–176
2. Weinblatt ME (1985) Toxicity of low dose methotrexate in rheumatoid arthritis. J Rheumatol Suppl 12(Suppl 12):35–39
3. James R (2005). Methotrexate, leflunomaide and combination therapies. In: Harris ED, Budd RC, Firestein GS, Genovese MC, Sergent JS, Ruddy S, Sledge C. (ed). Kelley’s Textbook.7th edn. Elsevier, Philadelphia, pp 900-919
4. Ohosone Y, Okano Y, Kameda H, Fujii T, Hama N, Hirakata M, Mimori T, Akizuki M, Ikeda Y (1997) Clinical characteristics of patients with rheumatoid arthritis and methotrexate induced pneumonitis. J Rheumatol 24:2299–2303
5. Gutierrez-Ureña S, Molina JF, García CO, Cuéllar ML, Espinoza LR (1996). Pancytopenia secondary to methotrexate therapy in rheumatoid arthritis. Arthritis Rheum 39:272–6